ASSESSMENT OF ANTIBIOTIC SYMPTOMS AND TREATMENT RESULTS HOSPITAL INFECTIONS BY KLEBSIELLA PNEUMONIAE AT DEPARTMENT INVENTORY CARE, NGHEAN GENERAL FRIENDSHIP HOSPITAL

Đức Phúc Nguyễn1,, Văn Thảnh Trần1
1 NGHE AN FRIENDSHIP GENERAL HOSPITAL

Main Article Content

Abstract

K.pneumoniae causes a variety of nosocomial infections, and the growing problem of antibiotic resistance over the past few decades has been a worldwide problem. Objectives: Evaluating antibiotic resistance and results of hospital antibacterial treatment due to Klebsiella pneumoniae at the Intensive Care Unit of Nghe An General Hospital. Subjects and methods: A cross-sectional descriptive study of 60 patients with resistance to K.pneumoniae hospital-acquired infections from January 2022 to August 2022. Results: The susceptibility of K.pneumoniae to the fosfomycin group was 62%; amikacin is 35%; carbapenems 20-30%; quinolones 10-12%. Mortality rate 26.67%; clinical response 56.7%; 40% microbiological response; appropriate empiric antibiotic 61.7%. Conclusion: The highest susceptibility of K.pneumoniae to the fosfomycin group was 62%; Mortality rate 26.67%; clinical response 56.7%; 40% microbiological response.

Article Details

References

1. Durdu B, Meric Koc M, Hakyemez IN, et al. Risk Factors Affecting Patterns of Antibiotic Resistance and Treatment Efficacy in Extreme Drug Resistance in Intensive Care Unit-Acquired Klebsiella Pneumoniae Infections: A 5-Year Analysis. Medical science monitor: international medical journal of experimental and clinical research. Jan 7 2019;25: 174-183. doi:10.12659/MSM.911338
2. Hoai NTT, Giang NNT, An HV. Hospital-acquired infections in ageing Vietnamese population: current situation and solution. MedPharmRes. May 01, 2020; 4(2):1-8. doi:https://doi.org/10.32895/UMP.MPR.4.2.1
3. Dat VQ. Addressing the Burden of Antimicrobial Resistance in Vietnamese Hospitals. Oxford University Clinical Research Unit Vietnam. The Open University. December 2019;6(3):1-8. http://oro.open.ac.uk/70201/.
4. Vardakas KZ, Matthaiou DK, Falagas ME, Antypa E, Koteli A, Antoniadou E. Characteristics, risk factors and outcomes of carbapenem- resistant Klebsiella pneumoniae infections in the intensive care unit. The Journal of infection. Jun 2015;70(6):592-9.
5. Ranjbar R, Fatahian Kelishadrokhi A, Chehelgerdi M. Molecular characterization, serotypes and phenotypic and genotypic evaluation of antibiotic resistance of the Klebsiella pneumoniae strains isolated from different types of hospital-acquired infections. Infection and drug resistance. 2019; 12:603-611. doi: 10.2147/ IDR. S199639
6. Wang Z, Qin RR, Huang L, Sun LY. Risk Factors for Carbapenem- resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection. Chinese medical journal. Jan 5 2018; 131(1): 56-62. doi: 10.4103/ 0366-6999. 221267
7. Pranita D. Tamma, Aitken SL, Bonomo RA, Mathers AJ, Duin Dv, Clancy CJ. Infectious diseases society of america antimicrobial resistant treatment guidance: Gram-negative bacterial infections. IDSA 9/8/2020; 9(3):2- 38.doi: https://www.idsociety.org/ practice-guideline/ amr-guidance/
8. Najmeddin F, Shahrami B, Azadbakht S, et al. Evaluation of Epithelial Lining Fluid Concentration of Amikacin in Critically Ill Patients With Ventilator-Associated Pneumonia. Journal of intensive care medicine. Apr 2020;35(4):400-404. doi:10.1177/0885066618754784